Tissue-engineered heart valve gains European market okay
This article was originally published in Clinica
Executive Summary
CryoLife has CE-marked for sale in Europe its tissue-engineered heart valve which the company claims is the only device of its kind that has the potential to repopulate itself with the patient's own cells.